UC San Diego and TSRI Launch New Consortium to Create ‘Virtual Cell’
Visible Molecular Cell Consortium will build bridges between disciplines and institutions to assemble and simulate a virtual model of a cell, down to an atomic level of detail.
Health & Behavior
The Latest
Targeted Drug Delivery With These Nanoparticles Can Make Medicines More Effective
Nanoparticles disguised as human platelets could greatly enhance the healing power of drug treatments for cardiovascular disease and systemic bacterial infections. These nanoparticles are capable of delivering drugs to targeted sites in the body — particularly injured blood vessels and organs infected by harmful bacteria. This targeted drug delivery greatly increased the therapeutic effects of drugs administered to diseased rats and mice.
NSF Locates National Nanotechnology Coordinated Infrastructure Site at UC San Diego
University selected for its unique strengths in nanobiology, nanophotonics and nanomagnetics research
Reduced Heart Rate Variability May Indicate Greater Vulnerability to PTSD
A prospective longitudinal study of U.S. Marines suggests that reduced heart rate variability – the changing time interval between heartbeats – may be a contributing risk factor for post-traumatic stress disorder (PTSD). The findings are reported in the September 9 online issue of JAMA Psychiatry by researchers at the University of California, San Diego School of Medicine and Veterans Affairs San Diego Healthcare System.
Identified Genetic Interaction Offers Possible New Target for Glaucoma Therapy
Scientists at the University of California, San Diego School of Medicine have elucidated a genetic interaction that may prove key to the development and progression of glaucoma, a blinding neurodegenerative disease that affects tens of millions of people worldwide and is a leading cause of irreversible blindness.
San Diego Events Map Future of Brain Research and Remedies
Two University of California, San Diego-sponsored events in September, over two consecutive Saturdays, highlight the importance of a comprehensive approach to brain research. First, on Sept. 12, is an education and advocacy forum for the public bringing together those affected by Alzheimer's disease, Parkinson's disease, brain injury, stroke, epilepsy, autism, mental illness or depression. Then on Sept. 19 a research symposium will connect local “neurotechnology” innovators to one another and to the region’s business community.
Stay in the Know
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
